Original Article

You have full text access to this OnlineOpen article

[F-18]-fluorodeoxy-D-glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults

  1. Douglas S. Hawkins MD1,†,*,
  2. Ernest U. Conrad III MD2,
  3. James E. Butrynski MD3,
  4. Scott M. Schuetze MD, PhD4,
  5. Janet F. Eary MD2

Article first published online: 10 JUN 2009

DOI: 10.1002/cncr.24421

Issue

Cancer

Cancer

Volume 115, Issue 15, pages 3519–3525, 1 August 2009

Additional Information

How to Cite

Hawkins, D. S., Conrad, E. U., Butrynski, J. E., Schuetze, S. M. and Eary, J. F. (2009), [F-18]-fluorodeoxy-D-glucose–positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer, 115: 3519–3525. doi: 10.1002/cncr.24421

Author Information

  1. 1

    Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington

  2. 2

    Departments of Orthopedics and Radiology, University of Washington Medical Center, Seattle, Washington

  3. 3

    Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

  4. 4

    Department of Medical Oncology, University of Michigan, Ann Arbor, Michigan

  1. †

    Fax: (206) 987-3946

*Seattle Children's Hospital, 4800 Sandpoint Way, Mailstop: B-6553, Seattle, WA 98105-0371

Publication History

  1. Issue published online: 20 JUL 2009
  2. Article first published online: 10 JUN 2009
  3. Manuscript Accepted: 16 JAN 2009
  4. Manuscript Revised: 18 DEC 2008
  5. Manuscript Received: 27 OCT 2008

Funded by

  • National Institutes of Health/National Cancer Institute. Grant Numbers: CA87721, CA65537

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (160K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Carola A.S. Arndt, Peter S. Rose, Andrew L. Folpe, Nadia N. Laack, Common Musculoskeletal Tumors of Childhood and Adolescence, Mayo Clinic Proceedings, 2012, 87, 5, 475

    CrossRef

  2. 2
    Junyu Guo, Wilburn E. Reddick, John O. Glass, Qing Ji, Catherine A. Billups, Jianrong Wu, Fredric A. Hoffer, Sue C. Kaste, Jesse J. Jenkins, Ximena C. Ortega Flores, Juan Quintana, Milena Villarroel, Najat C. Daw, Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma, Cancer, 2012, 118, 11
    Direct Link:
  3. 3
    Suman Malempati, Douglas S. Hawkins, Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies, Pediatric Blood & Cancer, 2012, 59, 1
    Direct Link:
  4. 4
    Anri Inaki, Junichi Taki, Hiroshi Wakabayashi, Hisashi Sumiya, Yoh Zen, Hiroyuki Tsuchiya, Seigo Kinuya, Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma, Annals of Nuclear Medicine, 2012,

    CrossRef

  5. 5
    Louie L. Gaston, Claudia Bella, John Slavin, Rodney J. Hicks, Peter F. M. Choong, 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different, Skeletal Radiology, 2011, 40, 8, 1007

    CrossRef

  6. 6
    Kevin London, Claudia Stege, Siobhan Cross, Ella Onikul, Nicole Graf, Gertjan Kaspers, Luciano Dalla-Pozza, Robert Howman-Giles, 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors, Pediatric Radiology, 2011, 42, 4, 418

    CrossRef

  7. 7
    Franziska Walter, Noah Federman, Wipapat Apichairuk, Scott Nelson, Michael E. Phelps, Martin Allen-Auerbach, Martin A. Walter, Johannes Czernin, 18F-FluoroDeoxyGlucose Uptake of Bone and Soft Tissue Sarcomas in Pediatric Patients, Pediatric Hematology-Oncology, 2011, 28, 7, 579

    CrossRef

  8. 8
    G. Grignani, E. Palmerini, P. Dileo, S. D. Asaftei, L. D'Ambrosio, Y. Pignochino, M. Mercuri, P. Picci, F. Fagioli, P. G. Casali, S. Ferrari, M. Aglietta, A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study, Annals of Oncology, 2011, 23, 2, 508

    CrossRef

  9. 9
    Elske Quak, Addy CM van de Luijtgaarden, Lioe-Fee de Geus-Oei, Winette TA van der Graaf, Wim JG Oyen, Clinical applications of positron emission tomography in sarcoma management, Expert Review of Anticancer Therapy, 2011, 11, 2, 195

    CrossRef

  10. 10
    Sue C. Kaste, Imaging Pediatric Bone Sarcomas, Radiologic Clinics of North America, 2011, 49, 4, 749

    CrossRef

  11. 11
    Stephan D. Voss, Pediatric oncology and the future of oncological imaging, Pediatric Radiology, 2011, 41, S1, 172

    CrossRef

  12. 12
    Winston W. Huh, Nancy Fitzgerald, Anita Mahajan, Erich M. Sturgis, R. Beverly Raney, Peter M. Anderson, Pediatric sarcomas and related tumors of the head and neck, Cancer Treatment Reviews, 2011, 37, 6, 431

    CrossRef

  13. 13
    Hyung Jun Im, Tae Sung Kim, Seog-Yun Park, Hye Sook Min, June Hyuk Kim, Hyun Guy Kang, Seung Eun Park, Mi Mi Kwon, Jong Hyung Yoon, Hyeon Jin Park, Seok-ki Kim, Byung-Kiu Park, Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 39, 1, 39

    CrossRef

  14. 14
    Erik Mittra, Andrei Iagaru, 18F-FDG-PET and PET/CT for Evaluating Primary Bone Tumors, PET Clinics, 2010, 5, 3, 327

    CrossRef

  15. 15
    Frederick D. Grant, Laura A. Drubach, S. Ted Treves, 18F-Fluorodeoxyglucose PET and PET/CT in Pediatric Musculoskeletal Malignancies, PET Clinics, 2010, 5, 3, 349

    CrossRef

  16. 16
    Timm Denecke, Patrick Hundsdörfer, Daniel Misch, Ingo G. Steffen, Stefan Schönberger, Christian Furth, Michail Plotkin, Juri Ruf, Hubertus Hautzel, Brigitte Stöver, Regine Kluge, Uta Bierbach, Sylke Otto, James F. Beck, Christiane Franzius, Günter Henze, Holger Amthauer, Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 10, 1842

    CrossRef

  17. 17
    Heather Magnan, Alexander J. Chou, Joanne F. Chou, Henry W.D. Yeung, John H. Healey, Paul A. Meyers, Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma, Cancer, 2010, 116, 17
    Direct Link:
  18. 18
    Sameer Bakhshi, Venkatraman Radhakrishnan, Prognostic markers in osteosarcoma, Expert Review of Anticancer Therapy, 2010, 10, 2, 271

    CrossRef

  19. 19
    David M. Loeb, Robert F. Hobbs, Amarachukwu Okoli, Allen R. Chen, Steve Cho, Senthamizhchelvan Srinivasan, George Sgouros, Ori Shokek, Moody D. Wharam, Tammy Scott, Cindy L. Schwartz, Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma, Cancer, 2010, 116, 23
    Direct Link:
  20. 20
    Chang-Bae Kong, Soo-Yong Lee, Dae-Geun Jeon, Staged Lengthening Arthroplasty for Pediatric Osteosarcoma around the Knee, Clinical Orthopaedics and Related Research®, 2009, 468, 6, 1660

    CrossRef

View Full Article (HTML) Get PDF (160K)